Antidepressant prevalence for youths: A multi-national camparison

Pharmacoepidemiology and Drug Safety

Volumn 15, Issue 11, 2006, Pages 793-798

  Zito, Julie M ^a   Tobi, Hilde ^b   de Jong van den Berg, Lolkje T W ^b   Fegert, Joerg M ^c   Safer, Daniel J ^d   Janhsen, Katrin ^e   Gilså Hansen, Dorte ^f   Gardner, James F ^a   Glaeske, Gerd ^e  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY OF ULM   (Germany)

^d DEPARTMENT OF PATHOLOGY   (United States)

^e UNIVERSITY OF BREMEN   (Germany)

^f UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

antidepressants; Children and adolescents; Pharmacoepidemiology

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; DOXEPIN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; OPIPRAMOL; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DATA BASE; DENMARK; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; FEMALE; GEOGRAPHIC DISTRIBUTION; GERMANY; HEALTH CARE UTILIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NETHERLANDS; PHARMACOEPIDEMIOLOGY; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PRIORITY JOURNAL; UNITED STATES; WESTERN EUROPE;

ADOLESCENT; AGE DISTRIBUTION; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DENMARK; DEPRESSIVE DISORDER; DRUG UTILIZATION; GERMANY; HUMANS; INFANT; INSURANCE CLAIM REPORTING; NETHERLANDS; PHARMACOEPIDEMIOLOGY; PHYSICIAN'S PRACTICE PATTERNS; POPULATION SURVEILLANCE; PREVALENCE; SEROTONIN UPTAKE INHIBITORS; SEX DISTRIBUTION; UNITED STATES;

EID: 33751103903     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1254     Document Type: Article

References (23)

1. Jureidini J, Doecke C, Mansfield P, Haby MM, Menkes DB, Tonkin AL. Efficacy and safety of antidepressants for children and adolescents. BMJ 2004; 328: 879-883.
2. Delate T, Gelenberg AJ, Simmons VA, Motheral BR. Trends in the use of antidepressants in a national sample of commercially insured pediatric patients, 1998 to 2002. Psychiatr Serv 2004; 55(4): 387-391.
3. Clavenna A, Bonati M, Rossi E, De Rosa M. Increase in non-evidence based use of antidepressants in children is cause for concern (letter). BMJ 2004; 328(7441): 711-712.
4. Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 2004; 363(9418): 1341-1345.
5. American College of Neuropsychopharmacology. Preliminary report on the task force on SSRIs and suicidal behavior in youth (Executive summary). 2004.
6. Vitiello B, Swedo S. Antidepressant medications in children. N Engl J Med 2004; 350(15): 1489-1491.
7. Olfson M, Shaffer D, Marcus SC, Greenberg T. Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry 2003; 60: 978-982.
8. Newman TB. A black-box warning for antidepressants in children? N Engl J Med 2004; 351(16): 1595-1598.
9. Garland EJ. Facing the evidence: antidepressant treatment in children and adolescents (Commentary). Can Med Assoc J 2004; 170(4): 489-491.
10. Byck GR. A comparison of the socioeconomic and health status characteristics of uninsured, State Children's Health Insurance Program-eligible children in the United States with those of other groups of insured children: implications for policy. Pediatrics 2000; 106(1 Pt 1): 14-21.
11. Tobi H, vandenBerg PB, deJong-vanden Berg L. Small proportions: what to report for CIs? Pharmacoepidemiology Drug Saf 2005; 14(4): 239-247.
12. Martin A, Leslie D. Trends in psychotropic medication costs for children and adolescents, 1997-2000. Arch Pediatr Adolesc Med 2003; 157(10): 997-1004.
13. Shatin D, Drinkard CR. Ambulatory use of psychotropics by employer-insured children and adolescents in a national managed care organization. Ambul Pediatr 2002; 2(2): 111-119.
14. Hugtenburg JG, Heerdink ER, Egberts ACG. Increased psychotropic drug consumption by children in the Netherlands during 1995-2001 is caused by increased use of methylphenidate by boys. Eur J Clin Pharmacol 2004; 60(5): 377-379.
15. Percudani M, Barbui C, Fortino I, Petrovich L. Worrying patterns of out-patient psychotropic drug prescribing in children and adolescents. Psychother Psychosom 2005; 74(3): 189-190.
16. Schirm E, Tobi H, Zito JM, De Jong-van den Berg LT. Psychotropic medication in children: a study from The Netherlands. Pediatrics 2001; 108(2): e25.
17. Olfson M, Gameroff MJ, Marcus SC, Waslik B. Outpatient treatment of child and adolescent depression in the United States. Arch Gen Psychiatry 2003; 60(12): 1236-1242.
18. Zito JM, Safer DJ, dosReis S, Gardner JF, Soeken K, Boles M, Lynch F. Rising prevalence of antidepressant treatments for U.S. youths. Pediatrics 2002; 109: 721-727.
19. Murray ML, de Vries CS, Wong ICK. A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database. Arch Dis Child 2004; 89(12): 1098-1102.
20. McManus P, Mant A, Mitchell PB, Montgomery WS, Marley JE, Auland ME. Recent trends in the use of antidepressant drugs in Australia, 1990-1998. Med J Aust 2001; 173(9): 458-461.
21. Thomsen PH, Kurita H. International perspectives. In Pediatric Psychopharmacology: Principles and Practice. Martin A, Scahill L, Charney DS, Leckman JF (eds). Oxford University Press: New York, 2003; 746-755.
22. Heyman I, Santosh P. Pharmacological and other physical treatments. In Child and Adolescent Psychiatry. Rutter M, Taylor E (eds). Oxford: Blackwell Science Ltd., 2002; 998-1018.
23. Graham P, Turk J, Verhulst F. Child Psychiatry: A Developmental Approach. 3rd edn.. Oxford University Press: New York, 1999.